Expand UTHR Menu
UTHR MENU

UTHR Latest Press Releases

-- September 8, 2026 --

United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization Business Wire 7:00 AM

-- September 2, 2026 --

United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso to Treat Idiopathic Pulmonary Fibrosis Business Wire 7:00 AM

-- September 1, 2026 --

United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences Business Wire 7:00 AM

-- August 28, 2026 --

United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026 Business Wire 7:00 AM

-- August 24, 2026 --

United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension Business Wire 7:00 AM

-- August 17, 2026 --

United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis Business Wire 7:00 AM

-- August 5, 2026 --

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results Business Wire 6:30 AM

-- July 29, 2026 --

United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Published in The Lancet Business Wire 6:30 AM

-- July 23, 2026 --

United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directors Business Wire 6:30 AM

-- July 22, 2026 --

United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026 Business Wire 7:00 AM

-- July 10, 2026 --

BETA Technologies and Multistate Collaborative Complete First Operational Flights of the U.S. DOT and FAA's eVTOL Integration Pilot Program Business Wire 12:35 PM

-- July 2, 2026 --

United Therapeutics Corporation Acquires Thymmune Therapeutics Business Wire 6:30 AM

-- June 29, 2026 --

United Therapeutics Corporation Announces FDA Approval of the LungFX Device for Centralized Ex Vivo Lung Perfusion Business Wire 6:30 AM

-- May 27, 2026 --

United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference Business Wire 7:00 AM

-- May 18, 2026 --

United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026 Business Wire 4:15 PM

-- May 17, 2026 --

United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026 Business Wire 2:15 PM

-- May 15, 2026 --

United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial Business Wire 6:00 PM

-- May 13, 2026 --

Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease PRNewswire 6:00 AM

-- May 12, 2026 --

United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference Business Wire 7:00 AM

-- May 11, 2026 --

United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026 Business Wire 6:30 AM

-- May 6, 2026 --

United Therapeutics Corporation Reports First Quarter 2026 Financial Results Business Wire 6:30 AM
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases Globe Newswire 6:30 AM

-- April 29, 2026 --

United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors Business Wire 7:00 AM
Market Data Delayed 15 Minutes